260 related articles for article (PubMed ID: 33125525)
1. Management of glucose profile throughout strict COVID-19 lockdown by patients with type 1 diabetes prone to hypoglycaemia using sensor-augmented pump.
Viñals C; Mesa A; Roca D; Vidal M; Pueyo I; Conget I; Giménez M
Acta Diabetol; 2021 Mar; 58(3):383-388. PubMed ID: 33125525
[TBL] [Abstract][Full Text] [Related]
2. The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 Diabetes prone to hypoglycemia using standalone continuous glucose monitoring.
Mesa A; Viñals C; Pueyo I; Roca D; Vidal M; Giménez M; Conget I
Diabetes Res Clin Pract; 2020 Sep; 167():108354. PubMed ID: 32739380
[TBL] [Abstract][Full Text] [Related]
3. Switching from Suspend-Before-Low Insulin Pump Technology to a Hybrid Closed-Loop System Improves Glucose Control and Reduces Glucose Variability: A Retrospective Observational Case-Control Study.
Lepore G; Scaranna C; Corsi A; Dodesini AR; Trevisan R
Diabetes Technol Ther; 2020 Apr; 22(4):321-325. PubMed ID: 31617752
[TBL] [Abstract][Full Text] [Related]
4. Impact of COVID-19 lockdown on flash and real-time glucose sensor users with type 1 diabetes in England.
Prabhu Navis J; Leelarathna L; Mubita W; Urwin A; Rutter MK; Schofield J; Thabit H
Acta Diabetol; 2021 Feb; 58(2):231-237. PubMed ID: 33067723
[TBL] [Abstract][Full Text] [Related]
5. "Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients.
Biester T; Kordonouri O; Holder M; Remus K; Kieninger-Baum D; Wadien T; Danne T
Diabetes Technol Ther; 2017 Mar; 19(3):173-182. PubMed ID: 28099035
[TBL] [Abstract][Full Text] [Related]
6. Coronavirus lockdown effect on type 1 diabetes management οn children wearing insulin pump equipped with continuous glucose monitoring system.
Christoforidis A; Kavoura E; Nemtsa A; Pappa K; Dimitriadou M
Diabetes Res Clin Pract; 2020 Aug; 166():108307. PubMed ID: 32650036
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial.
Bosi E; Choudhary P; de Valk HW; Lablanche S; Castañeda J; de Portu S; Da Silva J; Ré R; Vorrink-de Groot L; Shin J; Kaufman FR; Cohen O;
Lancet Diabetes Endocrinol; 2019 Jun; 7(6):462-472. PubMed ID: 31047902
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 Pandemic and Pediatric Type 1 Diabetes: No Significant Change in Glycemic Control During The Pandemic Lockdown of 2020.
Nwosu BU; Al-Halbouni L; Parajuli S; Jasmin G; Zitek-Morrison E; Barton BA
Front Endocrinol (Lausanne); 2021; 12():703905. PubMed ID: 34447352
[TBL] [Abstract][Full Text] [Related]
9. Impact of COVID-19 lockdown on glycemic control in type 1 diabetes.
Duarte V; Mota B; Ferreira S; Costa C; Correia CC
Arch Pediatr; 2022 Jan; 29(1):27-29. PubMed ID: 34955306
[TBL] [Abstract][Full Text] [Related]
10. The Medtronic 780G advanced hybrid closed-loop system achieves and maintains good glycaemic control in type 1 diabetes adults despite previous treatment.
Quirós C; Alonso-Carril N; Rodríguez-Rodríguez S; Barahona MJ; Orois A; Simó-Servat A; Ramos M; Perea V
Endocrinol Diabetes Nutr (Engl Ed); 2023 Feb; 70(2):130-135. PubMed ID: 36925230
[TBL] [Abstract][Full Text] [Related]
11. Impact of COVID-19 lockdown on glycemic control in patients with type 1 diabetes.
Fernández E; Cortazar A; Bellido V
Diabetes Res Clin Pract; 2020 Aug; 166():108348. PubMed ID: 32711000
[TBL] [Abstract][Full Text] [Related]
12. Impact of COVID-19 lockdown on glucemic control in children and adolescents with type 1 diabetes mellitus.
Sánchez Conejero M; González de Buitrago Amigo J; Tejado Bravo ML; de Nicolás Jiménez JM
An Pediatr (Engl Ed); 2022 Jul; 97(1):22-29. PubMed ID: 35725820
[TBL] [Abstract][Full Text] [Related]
13. Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy.
Longo M; Caruso P; Petrizzo M; Castaldo F; Sarnataro A; Gicchino M; Bellastella G; Esposito K; Maiorino MI
Diabetes Res Clin Pract; 2020 Nov; 169():108440. PubMed ID: 32926958
[TBL] [Abstract][Full Text] [Related]
14. Impact of Sensor-Augmented Pump Therapy with Predictive Low-Glucose Suspend Function on Glycemic Control and Patient Satisfaction in Adults and Children with Type 1 Diabetes.
Beato-Víbora PI; Quirós-López C; Lázaro-Martín L; Martín-Frías M; Barrio-Castellanos R; Gil-Poch E; Arroyo-Díez FJ; Giménez-Álvarez M
Diabetes Technol Ther; 2018 Nov; 20(11):738-743. PubMed ID: 30256132
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of telemedicine for persons with type 1 diabetes during Covid19 lockdown.
Boscari F; Ferretto S; Uliana A; Avogaro A; Bruttomesso D
Nutr Diabetes; 2021 Jan; 11(1):1. PubMed ID: 33414391
[TBL] [Abstract][Full Text] [Related]
16. Effect of predicted low suspend pump treatment on improving glycaemic control and quality of sleep in children with type 1 diabetes and their caregivers: the QUEST randomized crossover study.
Schierloh U; Aguayo GA; Fichelle M; De Melo Dias C; Celebic A; Vaillant M; Barnard K; Cohen O; de Beaufort C
Trials; 2018 Dec; 19(1):665. PubMed ID: 30509293
[TBL] [Abstract][Full Text] [Related]
17. Glycemic Control Improvement in Italian Children and Adolescents With Type 1 Diabetes Followed Through Telemedicine During Lockdown Due to the COVID-19 Pandemic.
Predieri B; Leo F; Candia F; Lucaccioni L; Madeo SF; Pugliese M; Vivaccia V; Bruzzi P; Iughetti L
Front Endocrinol (Lausanne); 2020; 11():595735. PubMed ID: 33424771
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Efficacy and Safety of Sensor Augmented Insulin Pump Therapy with Low-Glucose Suspend Feature in Patients with Type 1 Diabetes.
Gómez AM; Marín Carrillo LF; Muñoz Velandia OM; Rondón Sepúlveda MA; Arévalo Correa CM; Mora Garzón E; Cuervo Diaz MC; Henao Carrillo DC
Diabetes Technol Ther; 2017 Feb; 19(2):109-114. PubMed ID: 28001445
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of the predictive low glucose management system in the prevention of hypoglycaemia: protocol for randomised controlled home trial to evaluate the Suspend before low function.
Abraham MB; Nicholas JA; Ly TT; Roby HC; Paramalingam N; Fairchild J; King BR; Ambler GR; Cameron F; Davis EA; Jones TW
BMJ Open; 2016 Apr; 6(4):e011589. PubMed ID: 27084290
[TBL] [Abstract][Full Text] [Related]
20. The effect of COVID-19 lockdown on the glycemic control of children with type 1 diabetes.
Hakonen E; Varimo T; Tuomaala AK; Miettinen PJ; Pulkkinen MA
BMC Pediatr; 2022 Jan; 22(1):48. PubMed ID: 35045807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
